<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04200157</url>
  </required_header>
  <id_info>
    <org_study_id>18-00830</org_study_id>
    <nct_id>NCT04200157</nct_id>
  </id_info>
  <brief_title>Testing the Decoy Effect to Increase Tobacco Treatment Uptake</brief_title>
  <official_title>Testing the Decoy Effect to Increase Tobacco Treatment Uptake</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prior research has shown that the context in which program options are presented to consumer&#xD;
      impacts consumer choice (known as the 'decoy effect'). The aims of this study are to: (1)&#xD;
      test whether the decoy effect can impact smokers' selection of hypothetical tobacco treatment&#xD;
      options; (2) examine sociodemographic moderators of the decoy effect; and and (3) examine&#xD;
      whether presenting the time and clinical effectiveness of of the different treatment options&#xD;
      modifies the decoy effect.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will recruit and conduct a cross-sectional online survey through&#xD;
      ResearchMatch (www.researchmatch.org) with 600 tobacco users across the country. The survey&#xD;
      will ask participants for their preferences regarding hypothetical tobacco treatment&#xD;
      programs. Participants will be randomized to 12 conditions (n=50 per condition). Each&#xD;
      condition has a different combination of treatment options. The survey will also assess&#xD;
      sociodemographics and tobacco use behaviors. All participants will be asked if they would&#xD;
      like to receive information about the state's smoking cessation quitline. Participants who&#xD;
      would like to receive information will be given the 1800-QUIT-NOW number and smokefree.gov&#xD;
      website address.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 10, 2018</start_date>
  <completion_date type="Actual">July 22, 2019</completion_date>
  <primary_completion_date type="Actual">July 22, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of counseling calls chosen</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of weeks until quit date chosen</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_groups>12</number_of_groups>
  <enrollment type="Actual">600</enrollment>
  <condition>Tobacco Smoking</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions&#xD;
4 sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions&#xD;
4 sessions&#xD;
7 sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions&#xD;
7 sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions&#xD;
7 sessions&#xD;
10 sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions (30 minutes)&#xD;
4 sessions (60 minutes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions (30 minutes)&#xD;
4 sessions (60 minutes)&#xD;
7 sessions (105 minutes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions (30 minutes)&#xD;
7 sessions (105 minutes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions (30 minutes)&#xD;
7 sessions (105 minutes)&#xD;
10 sessions (150 minutes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>9</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions (30 minutes) - 10% chance of quitting&#xD;
4 sessions (60 minutes) - 30% chance of quitting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions (30 minutes) - 10% chance of quitting&#xD;
4 sessions (60 minutes) - 30% chance of quitting&#xD;
7 sessions (105 minutes) - 30% chance of quitting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>11</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions (30 minutes) - 10% chance of quitting&#xD;
7 sessions (105 minutes) - 30% chance of quitting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12</arm_group_label>
    <description>Group assigned to the following answer combination:&#xD;
2 sessions (30 minutes) - 10% chance of quitting&#xD;
7 sessions (105 minutes) - 30% chance of quitting&#xD;
10 sessions (150 minutes) - 30% chance of quitting</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Online survey</intervention_name>
    <description>Subjects will complete a single survey that takes 5-10 minutes to complete</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>10</arm_group_label>
    <arm_group_label>11</arm_group_label>
    <arm_group_label>12</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
    <arm_group_label>6</arm_group_label>
    <arm_group_label>7</arm_group_label>
    <arm_group_label>8</arm_group_label>
    <arm_group_label>9</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited from ResearchMatch.org. People who are in&#xD;
        ResearchMatch.org's database will be eligible if they are 18 years or older and self-report&#xD;
        current tobacco use.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Self-reported current tobacco use&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>NYU Langone Health - Translational Research Building</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 13, 2019</study_first_submitted>
  <study_first_submitted_qc>December 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2019</study_first_posted>
  <last_update_submitted>December 13, 2019</last_update_submitted>
  <last_update_submitted_qc>December 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

